Clinical Trial Update: Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel, cisplatin, and 5-fluorouracil followed by cetuximab and radiation therapy in locally advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)
• Radiation therapy

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-12